Clinical Trial Update: Open-label Adjunctive Zonisamide for Bipolar Disorder [Phase 4]

View source ↗

Summary

This is an open-label Phase 4 trial of adjunctive zonisamide for bipolar disorder that has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Zonisamide (zonisamide)

Snippet

Sponsor: Elan Pharmaceuticals | Conditions: Bipolar Disorders | Phase 4 | Status: TERMINATED